RXST FY 2024 Earnings — RxSight, Inc. Revenue & Financial Results | Market Cap Arena

RXSTRxSight, Inc.

$313M

FY 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$140M+57.1% YoY

Gross Profit

$99M70.7% margin

Operating Income

-$37M-26.3% margin

Net Income

-$27M-19.6% margin

EPS (Diluted)

$-0.71

Cash Flow

Operating Cash Flow

-$17M

Free Cash Flow

-$22M

Stock-Based Comp.

$25M

Balance Sheet

Total Assets

$319M

Total Liabilities

$37M

Stockholders' Equity

$281M

Cash & Equivalents

$17M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$140M	$89M	+57.1%
Gross Profit	$99M	$54M	+84.0%
Operating Income	-$37M	-$50M	+26.4%
Net Income	-$27M	-$49M	+43.5%